www.alldocs.info « cancers »
by www.alldocs.info
the most recent document references on :: cancers
Google
 
 Web   cancers.alldocs.info 
 
    Languages: malattie oncologiche  cancers  cancer  cancer  Krebse          Found 1931 documents         Page 55 of 65   Pages:  <<  <  50  51  52  53  54  55  56  57  58  59  60  >  >> 
 
 
 
   cancers cancers
     bladder cancer bladder cancer
     brain cancer brain cancer
     breast cancer breast cancer
     colon cancer colon cancer
     gastrointestinal cancer gastrointestinal cancer
     kidney cancer kidney cancer
     laryngeal cancer laryngeal cancer
     leukaemia leukaemia
     liver cancer liver cancer
     lung cancer lung cancer
     lymphoma lymphoma
     myeloma myeloma
     neuroblastoma neuroblastoma
     ovarian cancer ovarian cancer
     pancreatic cancer pancreatic cancer
     prostate cancer prostate cancer
     stomach cancer stomach cancer
     testicular cancer testicular cancer
     thyroid cancer thyroid cancer
     uterine cancer uterine cancer
     prevention prevention
     diagnosis diagnosis
     therapies therapies
  cancers.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [1621] Cancer survival, England and Wales, 1991-2001
      PDF [20,9 KB]  From [www.statistics.gov.uk]  Last viewed: 30.01.2005
31 October 2003 Issued by National Statistics 1 Drummond Gate London SW1V 2QQ Telephone Press Office 020-7533 5702 Public Enquiries 020-7533 5888 Statistician Mike Quinn 020-7533 5257 Email mike.quinn@ons.gov.uk Internet www.statistics.gov.uk/releases Cancer survival, England and Wales, 1991-2001 New survival statistics for cancers of the lung, breast (in women), colon and prostate for adult patients in England and Wales diagnosed during 1991-99 and followed up to 31 December 2001 are released today by the Office for National Statistics. Five-year age-standardised* relative survival rates for adult patients (aged 15-99 years) diagnosed with cancer during 1991-95 and 1996-99 are given in the table below for the four most common cancers in men and in women. These account for around ...

  [1622] CANCER LEADERSHIP COUNCIL
      PDF [13,5 KB]  From [www.colorectal-cancer.net]  Last viewed: 30.01.2005
Contact: 1301 K Street N.W. • Suite 800 East • Washington, D.C. 20005 Phone: 202-626-3970 • Fax: 202-626-3961 • www.cancerleadership.org A PATIENT -CENTERED F ORUM OF NATIONAL ADVOCACY ORGANIZATIONS ADDRESSING PUBLIC POLICY ISSUES IN CANCER CANCER LEADERSHIP COUNCIL C L C September 24, 2003 Dear Conferee: The undersigned organizations, representing cancer survivors, their caregivers, and researchers, would like to urge the conferees to include in the Medicare prescription drug bill a transition provision that would ensure cancer patients access to life-saving cancer therapies at the first available opportunity. In their deliberations on the Medicare prescription drug bill, both the House and Senate acknowledged the need for transitional coverage for certain drugs from January 2004 until the comprehensive prescription drug benefit becomes effective ...

  [1623] Oncology Interactive Education Series - Helping You Understand ...
      PDF [169,3 KB]  From [www.colorectal-cancer.net]  Last viewed: 30.01.2005
Oncology Interactive ™ Education Series http://www.OncologyInteractive.com e-mail: info@OncologyInteractive.com toll free:1-877-505-OIES(6437) OIES ™ Confusion and fear often follow a cancer diagnosis and do not leave until patients really understand the disease and the choices they face. Developed with a patient's need for information in mind, the Oncology Interactive ™ Education Series (OIES ™ ) teaches patients everything they need to know about their cancer , quickly and easily. 88% of OIES ™ users found it to be the most useful resource available 1 . Understanding Colorectal Cancer provides approximately 25 hours of comprehensive information covering topics such as anatomy, prevention and detection, screening, diagnosis, supportive care, staging, and diet and nutrition. Understanding of difficult ...

  [1624] FROM The Cancer Council NSW
      PDF [50,4 KB]  From [www.cancer.org.au]  Last viewed: 30.01.2005
Disclaimer This site is owned and operated by The Cancer Council Australia. The information on this website is provided for general information only. It is not intended as medical advice, and should not be relied upon as a substitute for consultations with qualified health professionals who can determine your individual medical needs. We hope this information will answer some of your questions and help you in thinking about further questions that you might want to ask your doctor or our Cancer Helpline - 13 11 20 (for the cost of a local call from anywhere in Australia). Author The Cancer Council Australia’s website has been developed and written by staff of The Cancer Council Australia (web development by NetX). Unless otherwise stated, all information provided on this website has been written by the Communications Manager and the Public Affairs Manager in consultation with ...

  [1625] Cancer Staging Manual
      PDF [180,8 KB]  From [www.dmc.org]  Last viewed: 30.01.2005
© 2002 American Joint Committee on Cancer (AJCC) Staging Forms Chapter 3. Lip and Oral Cavity Chapter 4. Pharynx (Including Base of Tongue, Soft Palate, and Uvula) Chapter 5. Larynx Chapter 6. Nasal Cavity and Paranasal Sinuses Chapter 7. Major Salivary Glands (Parotid, Submandibular, and Sublingual) Chapter 8. Thyroid Chapter 9. Esophagus Chapter 10. Stomach Chapter 11. Small Intestine Chapter 12. Colon and Rectum Chapter 13. Anal Canal Cancer Staging Manual Staging Forms Sixth Edition Frederick L. Greene, M.D. David L. Page, M.D. Irvin D. Fleming, M.D. April G. Fritz, C.T.R., R.H.I.T. Charles M. Balch, M.D. Daniel G. Haller, M.D. Monica Morrow, M.D. Editors There are no Staging Forms for Chapters 1, 2 and 47 of the AJCC Cancer Staging Manual . Chapter ...

  [1626] brain tumor treatment.PUB
      PDF [145,2 KB]  From [www.neurosurgerytoday.org]  Last viewed: 30.01.2005
Long before Columbus ever set sail for the New World, the Incas practiced primitive brain surgery. They used crude stone instruments for scalpels and fashioned rudimentary knives from copper, silver and gold. Those times are indeed ancient history when it comes to brain surgery. Neurosurgeons today use amazingly sophisticated techniques and tools, especially in treating brain tumors . In attacking a tumor , neurosurgeons rely on computers, MRIs and image-guidance technology to help them navigate through the complex terrain of the brain with greater precision. Brain tumors have long been difficult to treat. Because they occur at the control center for thought, emotion and physical function, neurosurgeons must be careful not to damage healthy brain tissue. Fortunately, the new sophisticated techniques and tools insure the safest and most complete ...

  [1627] Rural safety – skin cancer >
      PDF [193,0 KB]  From [www.nt.gov.au]  Last viewed: 30.01.2005
WH 15.04.04 Rural safety – skin cancer > This bulletin outlines some simple safety guidelines for those working in the rural industry and is one of a series on Rural Industry safety. Two out of every three Australians are likely to develop skin cancer . As a rural worker you spend most of your time during the day outside. You are therefore most at risk. Remember • You do not actually have to get sunburnt to damage your skin and risk skin cancer . • Skin cancers are mostly related to over-exposure to the sun taking place over a period of time. Most skin cancer can be prevented by protecting the skin from the sun Types of skin cancer There are various types of skin cancer : • Basal Cell Carcinoma - starts as a small lump which flattens out as it grows. One of the two most common growths. It can ...

  [1628] Iowa Comprehensive Cancer Control
      PDF [351,0 KB]  From [www.idph.state.ia.us]  Last viewed: 30.01.2005
IOWA CONSORTIUM FOR COMPREHENSIVE CANCER CONTROL Changing the Face of Cancer in Iowa A STATE PLAN FOR 2003 - 2005 July 2003 Page 2 ACKNOWLEDGEMENTS Changing the Face of Cancer : A State Plan for 2003 - 2005 is the result of a statewide, collaborative initiative, designed to improve the state's cancer preven- tion and control efforts. The plan was developed through the generosity and inter- est of many organizations and individuals contributing time, expertise, program resources, and financial support. The creation of the plan was guided by the Comprehensive Cancer Control Steering Committee. Members of the Steering Committee, recognized for their commitment to the comprehensive cancer control (CCC) initiative, are as follows: Maleka Ahmed, MD, Iowa Medical Society; Jane Condon, RN, BSN, MBA Calhoun County Health Department; ...

  [1629] Cancer Care Ontario Practice Guidelines Initiative
      PDF [402,5 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
Adjuvant Systemic Therapy for Node-negative Breast Cancer Practice Guideline Report #1-8 Members of the Breast Cancer Disease Site Group ORIGINAL GUIDELINE: November 12, 1998 NEW EVIDENCE ADDED TO GUIDELINE REPORT: February 2002 MOST RECENT LITERATURE SEARCH: May 1, 2003 The Breast Cancer Disease Site Group is rewriting this practice guideline report. The revised guideline report will incorporate all new evidence that has become available since the guideline was completed in 1998. The new evidence under review is identified in the update sections of the full report below. The current guideline recommendations remain in effect until the Breast Cancer Disease Site Group has completed their review of the new evidence. SUMMARY Guideline Question What is the role of systemic adjuvant therapy for women with node-negative breast cancer ? Target Population These ...

  [1630] Cancer Care Ontario Practice Guidelines Initiative
      PDF [145,1 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
Epirubicin, as a Single Agent or in Combination, for Metastatic Breast Cancer Practice Guideline Report # 1-6 B.P.Findlay, C. Walker-Dilks, K. Pritchard, and members of the Breast Cancer Disease Site Group and the Systemic Treatment Disease Site Group. ORIGINAL GUIDELINE: March 11, 1997 MOST RECENT LITERATURE SEARCH: April 30, 2003 NEW EVIDENCE ADDED TO GUIDELINE REPORT: February 2002 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question What is the effectiveness of epirubicin, compared with doxorubicin, in patients with metastatic breast cancer ? Target Population Women with metastatic breast cancer . Recommendations Epirubicin, at doses equivalent to doxorubicin, has been shown to be equally efficacious and less toxic than ...

  [1631] Cancer Care Ontario Practice Guidelines Initiative
      PDF [146,7 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
Adjuvant Systemic Therapy for Node-negative Breast Cancer Practice Guideline Report #1-8 Members of the Breast Cancer Disease Site Group ORIGINAL GUIDELINE: November 12, 1998 NEW EVIDENCE ADDED TO GUIDELINE REPORT: February 2002 MOST RECENT LITERATURE SEARCH: May 1, 2003 The Breast Cancer Disease Site Group is rewriting this practice guideline report. The revised guideline report will incorporate all new evidence that has become available since the guideline was completed in 1998. The new evidence under review is identified in the update sections of the full report below. The current guideline recommendations remain in effect until the Breast Cancer Disease Site Group has completed their review of the new evidence. SUMMARY Guideline Question What is the role of systemic adjuvant therapy for women with node-negative breast cancer ? Target Population These ...

  [1632] Cancer Care Ontario Practice Guidelines Initiative
      PDF [528,8 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
Epirubicin, as a Single Agent or in Combination, for Metastatic Breast Cancer Practice Guideline Report # 1-6 B.P.Findlay, C. Walker-Dilks, K. Pritchard, and members of the Breast Cancer Disease Site Group and the Systemic Treatment Disease Site Group. ORIGINAL GUIDELINE: March 11, 1997 MOST RECENT LITERATURE SEARCH: April 30, 2003 NEW EVIDENCE ADDED TO GUIDELINE REPORT: February 2002 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question What is the effectiveness of epirubicin, compared with doxorubicin, in patients with metastatic breast cancer ? Target Population Women with metastatic breast cancer . Recommendations Epirubicin, at doses equivalent to doxorubicin, has been shown to be equally efficacious and less toxic than ...

  [1633] Fox Chase Cancer Center Banks on Olympus
      PDF [399,5 KB]  From [www.olympusamerica.com]  Last viewed: 30.01.2005
When you’re at the helm of a thriving healthcare practice such as the Fox Chase Cancer Center, it’s easy to rest on your laurels. But when the dynamics of the healthcare profession force you to diversify, where do you turn for new technology and the capital with which to fund it? The answer for Fox Chase was clear, Olympus. In less than two years, this venerable Philadelphia-based institution has transformed itself into a model multi-discipline center for cancer screening and interventional endoscopy. The endoscopic equipment of choice comes from Olympus. And thanks to the innovative Cost Per Procedure ® (CPP ® ) program from Olympus Financial Services, ® three endoscopy rooms were equipped with leading-edge Olympus equipment without spending one cent of precious capital. The arrangement has also ...

  [1634] National Cancer Institute of Canada Welcomes new President
      PDF [46,3 KB]  From [www.cancerboard.ab.ca]  Last viewed: 30.01.2005
National Cancer Institute of Canada Welcomes New President For release: Thursday, June 20, 9 am Dr. Anthony Fields, a distinguished oncologist and senior cancer agency administrator who has played a leadership role in developing strategies to fight cancer in Canada, was appointed President of the National Cancer Institute of Canada (NCIC), effective June 14. Dr. Fields is Vice-President of Medical Affairs and Community Oncology at the Alberta Cancer Board and a medical oncologist specializing in the treatment of gastrointestinal malignancies. He is a former director of Alberta’s Cross Cancer Institute, an internationally known cancer treatment and research centre. “This is a pivotal time in cancer research," says Dr. Fields. "I’ve felt an excitement in the past five years that I haven’t experienced in the prior 20 years. The pace of new discoveries is accelerating. The NCIC’s ...

  [1635] SEER Cancer Statistics Review 1975-2000 National Cancer Institute
      PDF [74,3 KB]  From [seer.cancer.gov]  Last viewed: 30.01.2005
SEER Cancer Statistics Review 1975-2000 National Cancer Institute The APC is the Annual Percent Change based on rates age-adjusted to the 2000 U.S. standard population by 5-year age groups using the Joinpoint Regression Program. a Trends are from the SEER 9 areas. b Trends are from the NCHS public use data file. c The APC is significantly different from zero (p<.05). Joinpoint Segment 1 Joinpoint Segment 2 Joinpoint Segment 3 Joinpoint Segment 4 Year APC Year APC Year APC Year APC SEER Cancer Incidence a All Races All Ages 1975-2000 1.6 c All Races Under 50 1975-2000 1.8 c All Races 50 and Over 1975-2000 -0.3 White All Ages 1975-2000 1.8 c White Under 50 1975-1987 3.4 c 1987-2000 ...

  [1636] «Cure for All Cancers» by Hulda Clark
      PDF [139,4 KB]  From [www.swisscancer.ch]  Last viewed: 30.01.2005
Swiss Study Group for Complementary and Alternative Methods in Cancer SCAC Patronage: Swiss Society for Oncology (SGO), Swiss Society for Medical Oncology (SGMO), Swiss Institute for Applied Cancer Research (SIAK) «Cure for All Cancers » by Hulda Clark Documentation No. 01/01 Summary Based on the study of the literature and other available information, the Swiss Study Group for Complementary and Alternative Methods in Cancer (SCAC) and the Swiss Cancer League (SCL) have no evidence to prove that the «Cure for All Cancers » advocated by Hulda Clark brings about a cure in cases of cancer . For this reason, we must advise cancer patients against relying on the curative effect of this method, and we must also point out possible risks which the «Cure for All Cancers » entails. Claims advanced by the inventor/supplier Hulda Clark believes ...

  [1637] CANCER BIOLOGY PROGRAM
      PDF [24,1 KB]  From [www.stanford.edu]  Last viewed: 30.01.2005
642 Excerpt from Stanford Bulletin, 2002-03 CANCER BIOLOGY PROGRAM Chair and Program Director: Joseph S. Lipsick (Professor of Pathology) Committee on Cancer Biology: Steven Artandi (Assistant Professor of Medicine, Hematology), Laura Attardi (Assistant Professor of Radi- ation Oncology), Dean Felsher (Assistant Professor of Medicine, Oncology), Peter Jackson (Assistant Professor of Pathology), Joseph Lipsick (Professor of Pathology), Anthony Oro (Assistant Professor of Dermatology), Michael Simon (Associate Professor of Biological Sciences) Department Offices: MSOB 309, 251 Campus Drive Mail Code: 94305-5404 Department Phone: (650) 723-6198 Email: Gina.Johnson@stanford.edu Web site: http://www.med.stanford.edu/school/cancerbiology Courses given in Cancer Biology have the subject code CBIO. For a complete list of subject codes, see Appendix B. ...

  [1638] The NHS Cancer Plan
      PDF [358,4 KB]  From [image.guardian.co.uk]  Last viewed: 30.01.2005
The NHS Cancer Plan A plan for investment A plan for reform September 2000 ff f Page 2 Contents Foreword by the Secretary of State 3 Executive summary 5 Chapter One The challenge of cancer 16 Chapter Two Improving prevention 23 Chapter Three Improving screening 32 Chapter Four Improving cancer services in the community 43 Chapter Five Cutting waiting for diagnosis and treatment 48 Chapter Six Improving treatment 56 Chapter Seven Improving care 62 Chapter Eight Investing in staff 70 Chapter Nine Investing in facilities 83 Chapter Ten Investing in the future: research ...

  [1639] COLORECTAL CANCER: SIGNIFICANT PUBLIC MISCONCEPTIONS PERSIST ABOUT ...
      PDF [93,1 KB]  From [imedex.com]  Last viewed: 30.01.2005
June 3, 2003 COLORECTAL CANCER : SIGNIFICANT PUBLIC MISCONCEPTIONS PERSIST ABOUT CANCER SCREENING SECTION: EXPANDED REPORTING; Pg. 36 Nearly 40% of colorectal cancer specialists surveyed worldwide say the most common misconception about colorectal cancer screening is that the exam is painful. More than one-quarter (28%) of experts report the second largest misconception is the belief that physically fit people who practice good nutrition are not at risk for colorectal cancer . The survey, conducted by leading medical conference organizer Imedex, Inc., surveyed 262 medical and radiation oncologists, surgeons, and gastroenterologists and other leading oncology professionals worldwide. The most significant challenge in the battle against colorectal cancer - the second leading cancer killer in the United States and other countries - is convincing people to undergo regular ...

  [1640] There’s Been A Revolution In Cervical Cancer Screening and ...
      PDF [26,3 KB]  From [www.bassett.org]  Last viewed: 30.01.2005
There’s Been A Revolution In Cervical Cancer Screening and Prevention January is Cervical Health Awareness Month, a good time to educate women about cervical cancer , tests to detect it, and the best means of protecting ourselves against this disease. The Pap smear has been shown to be the most effective cancer screening tool ever developed. The impact of this widely available test over the past 60 years is immeasurable. Millions of women have been saved because of early detection with Pap tests since cervical cancer screening has been available and accepted as part of the routine gynecologic care of women in the United States. However, over the past six decades the test has been refined in order to detect the more common precancerous conditions (“dysplasias”) of the cervix which are usually easily treated in an office or clinic, without loss of fertility. At the same time that the Pap smear has been improved, ...

  [1641] HoskinsBreast cancer
      PDF [26,6 KB]  From [www.bassett.org]  Last viewed: 30.01.2005
Breast Cancer —Mammograms are still an effective tool Despite recent controversies over who should have mammograms, at what age, and how often, mammography (x-ray picture of the breast) remains the single most effective method for early detection of breast cancer . Early detection significantly decreases a woman’s risk of dying from breast cancer . What is cancer ? It is a group of diseases in which cells in the body become abnormal and divide without control. More cells are made than are needed and form a mass, or tumor . As the tumor continues to grow, it damages and grows into nearby tissues and organs. Finally, cells can break away and enter the blood stream or lymphatic system, spreading to distant places in the body. This is called metastasis. Breast cancer is a growth of abnormal, malignant cells in the breast. Most breast cancers occur in women, but about one percent of breast cancer ...

  [1642] skin cancer prevention
      PDF [31,2 KB]  From [www.bassett.org]  Last viewed: 30.01.2005
Warm weather isn’t far away Prevention is the key to avoiding skin cancer Skin cancer is the world’s most common form of cancer with over 1.3 million cases occurring each year. This number is increasing yearly at an alarming rate and this region is no exception. The month of May is dedicated to skin cancer awareness and detection and we are hoping that sharing information about this worsening epidemic and encouraging people to take more protective measures this summer will help reduce the number of cases of skin cancer . There are many forms of skin cancer , 95 percent of which are curable when detected and treated early . Basal cell cancer is the most common form of skin cancer , and usually presents as a non-healing or scabby area that does not go away. They are usually slow- growing, rarely metastasize (spread to distant areas of the body) and are highly treatable with a variety ...

  [1643] Ontario Cancer Treatment Practice Guidelines Initiative
      PDF [158,2 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus Practice Guideline Report #2-12 Wong RKS, Malthaner RA, Zuraw L, Rumble RB, and members of the Gastrointestinal Cancer Disease Site Group. Report Date: August 18, 2003 ORIGINAL GUIDELINE: April 17, 2002 MOST RECENT LITERATURE SEARCH: May 13, 2003 NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 26, 2003 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question Does combined modality radiotherapy and chemotherapy improve survival compared with radiotherapy alone in patients with localized carcinoma of the esophagus for whom a non-surgical approach is used? Target Population These recommendations apply to adult patients with localized (T1-3, ...

  [1644] Cancer Care Ontario Practice Guidelines Initiative
      PDF [188,9 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
The Role of Thoracic Radiotherapy as an Adjunct to Standard Chemotherapy in Limited-Stage Small Cell Lung Cancer Practice Guideline Report #7-13-3 Okawara G, Gagliardi A, Evans WK, and members of the Lung Cancer Disease Site Group ORIGINAL GUIDELINE: October 8, 1999 RECOMMENDATIONS MODIFIED: January 2003 MOST RECENT LITERATURE SEARCH: December 2002 NEW EVIDENCE ADDED TO GUIDELINE REPORT: January 2003 Based on new evidence that emerged after completion of the original guideline, the Lung Cancer Disease Site Group modified the guideline recommendations in January 2003. The revised recommendations are labelled Update . SUMMARY Guideline Question Is there a role for thoracic radiotherapy as an adjunct to standard chemotherapy in limited-stage small cell lung cancer ? Target Population These recommendations apply to adult patients with limited-stage ...

  [1645] Ontario Cancer Treatment Practice Guidelines Initiative
      PDF [580,1 KB]  From [www.cancercare.on.ca]  Last viewed: 30.01.2005
Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus Practice Guideline Report #2-12 Wong RKS, Malthaner RA, Zuraw L, Rumble RB, and members of the Gastrointestinal Cancer Disease Site Group. Report Date: August 18, 2003 ORIGINAL GUIDELINE: April 17, 2002 MOST RECENT LITERATURE SEARCH: May 13, 2003 NEW EVIDENCE ADDED TO GUIDELINE REPORT: June 26, 2003 New evidence found by update searches since completion of the original guideline is consistent with the original recommendations. SUMMARY Guideline Question Does combined modality radiotherapy and chemotherapy improve survival compared with radiotherapy alone in patients with localized carcinoma of the esophagus for whom a non-surgical approach is used? Target Population These recommendations apply to adult patients with localized (T1-3, ...

  [1646] CANCER PRELIMS a
      PDF [795,1 KB]  From [www.health.gov.au]  Last viewed: 30.01.2005
N a t i o n a l H e a l t h P r i o r i t y A r e a s AUSTRALIAN INSTITUTE OF HEALTH & WELFARE Page 2 National Health Priority Areas Report Cancer control 1997 Commonwealth Department of Health and Family Services Australian Institute of Health and Welfare AIHW Cat. No. PHE 4 Page 3 © Commonwealth of Australia 1998 ISBN 0 642 36727 2 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced without written permission from AusInfo. Requests and enquiries concerning reproduction and rights should be directed to the Manager, Legislative Services, AusInfo, GPO Box 84, Canberra ACT 2601. Commonwealth Department of Health and Family Services and Australian Institute of Health and Welfare 1998. National ...

  [1647] WINSHIP CANCER INSTITUTE
      DOC [49,7 KB]  From [www.winshipcancerinstitute.org]  Last viewed: 30.01.2005
  cancer      Prostate Cancer Resources  INFORMATION AND SUPPORT RESOURCES   This Resource List is provided solely as a reference tool and in no way constitutes an endorsement or recommendation by Emory Healthcare or Emory University of the websites or programs listed.  Further, neither Emory Healthcare nor Emory University has reviewed the accuracy or the content of these websites or programs.  Therefore, you are encouraged to contact these organizations directly to verify and/or obtain additional information regarding the various benefits and programs.   American Cancer Society       www.2. cancer .org         American Foundation for Urologic Disease www.afud.org   American Prostate Society 410-859-3735 www.ameripros.org   Association for the Cure of Cancer of the Prostate ...

  [1648] COLORECTAL CANCER
      DOC [49,2 KB]  From [www.winshipcancerinstitute.org]  Last viewed: 30.01.2005
  cancer  COLORECTAL CANCER INFORMATION AND SUPPORT RESOURCES       This Resource List is provided solely as a reference tool and in no way constitutes an endorsement or recommendation by Emory Healthcare or Emory University of the websites or programs listed.  Further, neither Emory Healthcare nor Emory University has reviewed the accuracy or the content of these websites or programs.  Therefore, you are encouraged to contact these organizations directly to verify and/or obtain additional information regarding the various benefits and programs. American College of Gastroenterology 4900B South 31st Street Arlington, VA  22206 (703) 820-7400 http://www.acg.gi.org Provides education material including a glossary of GI terms and digestive health tips.     American Gastroenterological Assoc. 7910 Woodmont Avenue, 7th Floor Bethesda, MD  20814 (301) ...

  [1649] Cancer-Related Fatigue
      PDF [85,1 KB]  From [www.harcourt-international.com]  Last viewed: 30.01.2005
C H A P T E R T E N Cancer -Related Fatigue Fatigue has been called “the most important untreated symptom in cancer today.” 1 Although improvements have been seen in a number of areas of cancer management, such as pain, depression, and nausea and vomiting, fatigue remains inade- quately discussed and undertreated. 1 The reasons for this are varied. First, as with fatigue in most dis- eases, cancer -related fatigue is largely a subjective experience,and relies on self-reporting.Also,physi- cians and patients alike may view cancer -related fatigue as something to be endured, rather than a true symptom that requires an intervention. Third, it may be too easy to overlook a symptom such as fatigue when focusing on aggressive management of the tumor to ensure the patient’s survival. 131 H7038-10 23/1/03 17:48 ...

  [1650] YOUNG ADULTS WITH CANCER
      DOC [44,0 KB]  From [www.winshipcancerinstitute.org]  Last viewed: 30.01.2005
  cancer      YOUNG ADULTS WITH CANCER RESOURCE GUIDE     This Resource List is provided solely as a reference tool and in no way constitutes an endorsement or recommendation by Emory Healthcare or Emory University of the websites or programs listed.  Further, neither Emory Healthcare nor Emory University has reviewed the accuracy or the content of these websites or programs.  Therefore, you are encouraged to contact these organizations directly to verify and/or obtain additional information regarding the various benefits and programs.   Lance Armstrong Foundation www.laf.org   Cancer and Careers for working women www.cancerandcareers.org   Gilda?s Club www.gildasclub.org   Planet Cancer : A World of Support for Young Adults with Cancer www.planetcancer.org   Pregnant with Cancer Support Organization ...